Publication
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
Diana Crivellari, Kathryn P. Gray, Silvia Dellapasqua, Fabio Puglisi, Karin Ribi, Karen N. Price, István Láng, Lorenzo Gianni, Simon Spazzapan, Graziella Pinotti, Jean-Marc Lüthi, Richard D. Gelber, Meredith M. Regan, Marco Colleoni, Monica Castiglione-Gertsch, Rudolf Maibach, Manuela Rabaglio, Alan S. Coates, Aron Goldhirsch
The Breast, April 2013, Elsevier
DOI: 10.1016/j.breast.2013.01.015